Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
INN-PF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Should Value Investors Buy Community Healthcare Trust (CHCT) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to…
Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)
Second Quarter 2026 Results: Gross Margin of 90.9% and Category Leadership HERZLIYA, Israel and CALGARY, Alberta, Aug. 31, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ("Innocan" or the "Company"), today repor…
Summit Hotel Properties Q2 Earnings Call Highlights
Key Points Interested in Summit Hotel Properties, Inc.? Here are five stocks we like better. Summit Hotel Properties exceeded its second-quarter expectations, with RevPAR up 5%, hotel EBITDA up 7.8%, adjusted EBITDAre up 7.7% to $54.8 mill…
Summit Hotel Properties (INN) Q2 FFO and Revenues Beat Estimates
Summit Hotel Properties (INN) came out with quarterly funds from operations (FFO) of $0.29 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to FFO of $0.27 per share a year ago. These figures are adjusted f…
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Pelagos Insurance Capital Limit PLGO: This insurance and reinsurance company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over th…
NETSTREIT (NTST) Q2 FFO and Revenues Beat Estimates
NETSTREIT (NTST) came out with quarterly funds from operations (FFO) of $0.35 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to FFO of $0.33 per share a year ago. These figures are adjusted for non-recurr…
Should Value Investors Buy Summit Hotel Properties (INN) Stock?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growt…
Summit Hotel Properties Q1 Earnings Call Highlights
Summit Hotel Properties logo Key Points Summit’s Q1 results beat expectations as pro forma RevPAR rose 0.2% for the quarter with a sharp March acceleration (+4.1% RevPAR, +5.6% average rate), and management now expects RevPAR gains to be p…
Why The Summit Hotel Properties (INN) Story Is Shifting With Lower Targets And New 2026 Models
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The reset in Summit Hotel Properties’ price target from $8 to $6 puts a fresh spotlight on how anal…
Summit Hotel Properties Q4 Earnings Call Highlights
Summit Hotel Properties logo Key Points Fourth-quarter demand improved sequentially with management saying same-store RevPAR fell about 1.6% (pro forma -1.8%), but excluding a roughly 20% drop in government and inbound international travel…
NETSTREIT (NTST) came out with quarterly funds from operations (FFO) of $0.33 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.32 per share a year ago. These figures are adjusted for non-recurring items. Th…
Stride and Summit Hotel have been highlighted as Zacks Bull and Bear of the Day
For Immediate Release Chicago, IL – September 5, 2025 – Zacks Equity Research shares Stride, Inc. LRN as the Bull of the Day and Summit Hotel Properties INN as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Mc…
Summit Hotel Properties (INN) is a real estate investment trust (REIT) focused on premium-branded lodging facilities such as Hyatt Place. INN’s bottom line has been trending in the wrong direction as it deals with a shifting business and b…
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Summit Hotel Properties INN is a publicly traded real estate investment trust focused primarily on owning premium-branded, select-service hotels in the upscale and…
Innocan Pharma Announces Details of Proposed Share Consolidation
HERZLIYA, Israel and CALGARY, Alberta, Aug. 29, 2025 /CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release dated July 23, 2025, it wi…
Innocan Pharma Reports Successful Results of Efficacy Test for Vaginal Derma Product
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 23, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative…
Innocan Pharma Announces Launch of CBD Veterinary Commercialization Team
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 17, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative…
Innocan Pharma Announces First Patent Grant in the United States
This is the first fully granted patent of Innocan in the United States The Patent covers Innocan's proprietary cannabis-based pain relief topical This serves as an indication of Innocan's growing intellectual property portfolio Herzliya, I…
SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS
Cision Fourth Quarter 2022 RevPAR Recapture Reaches New High Operating Income Triples Driving Adjusted EBITDAre Growth of 100% to $180.8 Million in 2022 Nearly $1 Billion of Strategic Acquisitions Completed in 2022 AUSTIN, Texas, Feb. 27,…
Summit Hotel Properties Announces 2023 Annual Meeting of Stockholders
AUSTIN, Texas, Feb. 23, 2023 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that its 2023 Annual Meeting of Stockholders will be held Wednesday, May 24, 2023, beginning at 8:00 a.m. Central Time.…
Innocan Pharma Reports Clinical Success in Canine Compassionate Care Trial
"Lady", an 11-year-old female dog was presented to Innocan labs suffering from severe autoimmune mediated polyarthritis. Lady was treated with Glycoflex, steroids, and hydrotherapy, but still suffered pain and had difficulty walking more t…
Innocan Pharma Provides Annual "State of the Business" Update
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - February 16, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovati…
SUMMIT HOTEL PROPERTIES DECLARES FOURTH QUARTER 2022 DIVIDENDS
AUSTIN, Texas, Jan. 26, 2023 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the fourth quarter ended…
SUMMIT HOTEL PROPERTIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 EARNINGS RELEASE DATE
AUSTIN, Texas, Jan. 10, 2023 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it will report financial results for the fourth quarter and full year of 2022 on Monday, February 27, 2023, after t…
Innocan Pharma Signs a First Consulting Agreement to Commercialize its Pharmaceutical IP in the Veterinary Field
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - December 2, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovati…
Innocan Pharma Reports Q3 2022 Results with 700% Increase in Revenues Compared to Q3 2021
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovati…
Mr. Givi Topchishvili to Join Innocan Pharma's Advisory Committee
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 18, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovat…
Innocan Pharma Goes Live with Priority(TM) ERP System
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 9, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovativ…
SUMMIT HOTEL PROPERTIES PUBLISHES 2022 CORPORATE RESPONSIBILITY REPORT
AUSTIN, Texas, Nov. 7, 2022 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced the publication of its annual Corporate Responsibility Report for 2022, which presents the Company's ongoing commitment t…
SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2022 RESULTS
Same Store RevPAR Increases 24%; 2019 RevPAR Recapture Reaches New Quarterly High of 95% Acquisition of High-End Glamping Asset Onera Fredericksburg Completed AUSTIN, Texas, Nov. 2, 2022 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE:…
SUMMIT HOTEL PROPERTIES DECLARES THIRD QUARTER 2022 DIVIDENDS
AUSTIN, Texas, Oct. 28, 2022 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company"), announced today that its Board of Directors has authorized, and the Company has declared, a cash dividend for the third quarter ended S…
Innocan Pharma to Participate in IR Labs' Investor Webinar on November 2, 2022
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 25, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovativ…
Innocan Pharma to Participate in the Luxury Meets CBD Conference on October 20 & 21 in New York
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 13, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) a pharmaceutical tech company focusing on developing innovative drug…
Innocan Pharma's Patent Application for Treatment of Psoriasis of the Scalp Reached National Phase
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 6, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical tech company focusing on developing innovative drug…
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 21, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical tech company focuses on developing innovative dru…
SUMMIT HOTEL PROPERTIES ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE
AUSTIN, Texas, Sept. 20, 2022 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it will report financial results for the third quarter of 2022 on Wednesday, November 2, 2022, after the market cl…